Eugenio Morelli, MD, is an Instructor in Medicine at the Dana-Farber Cancer Institute and Harvard Medical School. Dr. Morelli's research interest is to decode the key oncogenic features of noncoding RNAs (ncRNA) to inform ncRNA-based therapies in multiple myeloma (MM). Dr. Morelli earned his MD degree magna cum laude in 2011 at the Magna Graecia University of Catanzaro (Catanzaro, Italy) and from 2012 to 2017 completed a clinical/research fellowship in Medical Oncology at the same Institution. In 2017, Dr. Morelli joined the Nikhil C Munshi Lab at the Jerome Lipper Multiple Myeloma Center at the Dana-Farber Cancer Institute and Harvard Medical School (Boston, MA, USA), where he has been working since then. Dr. Morelli has a demonstrated record of accomplished and productive research projects. In recognition of his research prowess, Dr. Morelli was awarded the International Myeloma Foundation (IMF) Brian D Novis Award and the Dana-Farber/Harvard Cancer Center SPORE in Multiple Myeloma Career Enhancement Award.